Prednisolone mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Prednisolone Mechanism of Action: Glucocorticoid Receptor Activation and Gene Regulation
Prednisolone is a synthetic glucocorticoid that works primarily by binding to glucocorticoid receptors inside cells. Once inside the cell, prednisolone enters the nucleus and attaches to specific nuclear receptors. This interaction changes the expression of certain genes, leading to reduced production of proinflammatory cytokines, decreased numbers of circulating lymphocytes, and increased cell differentiation and apoptosis in sensitive cells. These actions are central to its anti-inflammatory and immunosuppressive effects 8Van Laar2023.
Anti-Inflammatory and Immunosuppressive Effects
Prednisolone suppresses inflammation by inhibiting the production of molecules that promote immune cell activation and migration. It reduces the expression of cellular adhesion molecules (CAMs) such as P-selectin and ICAM-1, which are necessary for inflammatory cells to infiltrate tissues. This leads to fewer macrophages, T-cells, and eosinophils in inflamed tissues, as seen in models of muscle inflammation and dystrophin-deficient muscle . Additionally, prednisolone inhibits the polarization of monocytes and macrophages toward the pro-inflammatory M1 phenotype and suppresses the expression of inflammatory markers and matrix metalloproteinases .
Inhibition of Platelet Activation and Thromboxane A2 Generation
Prednisolone also affects platelet function by inhibiting the generation of thromboxane A2 (TxA2), a molecule important for platelet aggregation. It does this by regulating the phosphorylation of cytosolic phospholipase A2 (cPLA2), which is necessary for TxA2 production. This action helps explain prednisolone’s effects on coagulation and its potential role in bleeding and thrombotic disorders .
Effects on Erythropoiesis and Leukocyte Mitosis
Prednisolone can suppress the formation of red blood cells (erythropoiesis) by reducing the number and responsiveness of stem cells to erythropoiesis-stimulating factors and by decreasing the production of these factors at higher doses . It also inhibits the mitotic activity of leukocytes, mainly by preventing partially differentiated cells from becoming capable of division, rather than directly stopping mitosis .
Tissue-Specific Actions on RNA Synthesis
Prednisolone acts differently in various tissues. In the liver, it increases the content and synthesis of ribosomal RNA, while in muscle tissue, it decreases both. This suggests that prednisolone’s effects are selective and tissue-specific, enhancing protein synthesis in some tissues and suppressing it in others .
Modulation of Circadian Rhythm and Melatonin Secretion
Prednisolone can disrupt circadian rhythms and sleep by inhibiting melatonin secretion. It does this by acting through the glucocorticoid receptor to repress genes involved in melatonin production, leading to sleep disturbances, as observed in animal models .
Presynaptic Effects at Neuromuscular Junctions
At the neuromuscular junction, prednisolone increases the frequency and amplitude of miniature end-plate potentials, suggesting a presynaptic facilitatory effect. This may help explain its usefulness in conditions like myasthenia gravis, where neuromuscular transmission is impaired .
Conclusion
Prednisolone exerts its effects through multiple mechanisms: activating glucocorticoid receptors to regulate gene expression, suppressing immune and inflammatory responses, inhibiting platelet activation, altering erythropoiesis and leukocyte division, modulating tissue-specific RNA synthesis, disrupting circadian rhythms, and facilitating neuromuscular transmission. These diverse actions explain its wide use in treating inflammatory, autoimmune, and some hematological and neuromuscular disorders Kim2023Gordon1967Jiang2022+7 MORE.
Sources and full results
Most relevant research papers on this topic